Table: begin end state 1 17 cytoplasmic 18 38 transmembrane 39 53 non-cytoplasmic 54 75 transmembrane 76 95 cytoplasmic 96 119 transmembrane 120 130 non-cytoplasmic 131 152 transmembrane 153 156 cytoplasmic 157 174 transmembrane 175 178 non-cytoplasmic 179 203 transmembrane 204 209 cytoplasmic 210 231 transmembrane 232 244 non-cytoplasmic 245 265 transmembrane 266 272 cytoplasmic 273 291 transmembrane 292 324 non-cytoplasmic 325 344 transmembrane 345 361 cytoplasmic 362 388 transmembrane 389 407 non-cytoplasmic 408 425 transmembrane 426 456 cytoplasmic
Input: >WP_012591091.1 NCBI__GCF_000021745.1:WP_012591091.1 MQSSLTPARSRSRLKDALTGAAIAGAIMFGLCFPILAFRTDQNFSNELYLLSRWPAVAFA VGAVFVLRFAMLMLPPREPRPQAPPSPARAGALQRLARYAGAVGILALIAFPLVMVALLG PAGAQKWIDNFGVQILLYVLLGWGLNIVVGLAGLLDLGYVAFYAVGAYAYALLATHFGWS FWLCLPVAGLLAAGFGVALGLPVLRLRGDYLAIVTMAFGEIIRLVLTNWTALTNGDAGIS SIPRITFFGWPFIAGPNGFAALFGLKFAPVHRLIFLFYLILALALCVNYLTRRLRKAPLG RAFEALREDEIACRSLGVDTVATKLTAFALGASIAGMAGALFAARQNFVSPTSFTFMESA TILALVVLGGAGSQLGVALAAIVIIGGSEILRELDGLKQIFGPAFDPTQYRMLIVGIAMV GMMNWRPRGLIALRTPSIFLKKPKLVVGALAGEGRG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server